Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Issue: Reiterate the importance of animal models in medical research.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Issue: Support unique mission of academic medicine.

P.L. 117-180, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Issues: Support temporary extension of federal funding levels. Support supplemental funding for COVID-19 and Monkeypox response efforts, including testing. Oppose inclusion of policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food and Drug Administration regulation of the development of Laboratory Developed Tests at academic medical centers.

Presidents FY 2023 Budget Request
H.R. 8295, S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
P.L. 117-328, Consolidated Appropriations Act, 2023, Division H
Draft Presidents FY 2024 Budget Request
Issues: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, emerging special pathogens and public health preparedness programs. Support mandatory funding for public health preparedness. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Support animal research and oppose efforts to increase burden on researchers unnecessarily. Ensure investment in Advanced Research Projects Agency for Health does not supplant NIH funding. Oppose arbitrary restrictions on specific types and sites of research. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH), Prevention Research Centers, hospital-based and community violence interventions, data modernization, outbreak forecasting, and climate and health, and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic. Support ongoing investment in public health infrastructure. Support funding for maternal health and mortality improvement initiatives. Support expansion of CDC-supported genomic sequencing. Support increased funding for Telehealth Resource Centers.

Issue: Support investment in nondefense discretionary spending, including ample funding allocations for Labor-HHS-Education.

Presidents FY 2023 Budget Request
H.R. 8256, S. 4664, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023
P.L. 117-328, Consolidated Appropriations Act, 2023, Division B
Draft FY 2024 Presidents Budget
Issues: Support funding for the National Science Foundation (NSF)

Presidents FY 2023 Budget Request
H.R. 8238, S. 4759, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
P.L. 117-328, Consolidated Appropriations Act, 2023, Division J
Draft Presidents FY 2024 Budget Request
Issues: Support funding for Veterans Affairs medical research, research infrastructure, information technology, and community care. Oppose restrictions on use of canines in VA medical research. Oppose VA research funding rescissions. Support removing VA health funding from discretionary caps.

P.L. 117-2, American Rescue Plan
Issue: Encourage agencies to implement funding relief for federal research agencies, new COVID-19 research, funding for data science, CDC-supported genomic sequencing, public health data modernization, investment in public health infrastructure, testing, contact tracing, vaccine development and distribution. Support funding for provider relief fund. Support supplemental funding for HRSA workforce programs and programs addressing the mental health and well-being of health care providers. Support funding for increased FMAP for new states to expand Medicaid. Support funding for COBRA premium assistance. Support expanded subsidies in the ACA marketplaces. Support extension of postpartum Medicaid and CHIP coverage for 12 months. Support extension of Medicare sequester.

P.L. 117-169, Inflation Reduction Act of 2022
Issue: Support funding for pandemic resilience, funding for research and development, and VA hospital infrastructure. Support increased Medicare and VA support for physician training and the physician workforce. Support maximum funding for public health and health care preparedness. Support funding for research infrastructure and research recovery. Support funding for broadband access and other physical infrastructure. Support funding for capital projects at hospitals to enhance preparedness and expand ICU capacity. Support funding for grants between public health departments and academic medical centers. Support funding for maternal health. Support policies allowing teaching hospitals, medical schools, and other non-profit or public entities to access sustainable infrastructure investments. Support policies to reduce prescription drug prices. Support policies to increase non-profit entities access to funding for sustainable infrastructure.

H.R. 7007, Making emergency supplemental appropriations for coronavirus response and relief for the fiscal year ending September 30, 2022, and for other purposes.
Draft Senate Supplemental Administration's emergency supplemental funding request to address COVID.
P.L. 117-328, Consolidated Appropriations Act, 2023
Issue: Support emergency funding for HHS to address COVID.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, White House Office, Office of Management & Budget (OMB), U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), Natl Security Council (NSC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Issue: Reiterate the role the Bayh-Dole Act plays in fostering scientific innovation and economic growth, and reiterate that march-in was not an intended mechanism to reduce drug prices.

17. House(s) of Congress and Federal agencies Check if None

Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

Draft Higher Education Act Reauthorization
H.R. 8655, Responsible Education Assistance through Loan (REAL) Reforms Act
H.R. 8872, Lowering Obstacles to Achievement Now (LOAN) Act
Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF), and elimination of GradPLUS loans.

H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act
Issue: Support loan forgiveness for COVID-19 health workers.

S. 847, Student Loan Tax Elimination Act
Issue: Support the elimination of origination fees on federal student loans.

Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.

H.R. 801, the Expanding Medical Education Act
Issue: Support grants to create, expand, and support medical schools and regional medical campuses.

Issue: Support Pathway to Practice scholarships for underrepresented students entering medical school.

H.R. 9105, National Medical Corp Act
Issue: Support recruiting students from community college to careers in medicine to help improve physician workforce diversity.

Issue: Educate Congress on the role academic medicine can serve with the Commission on the Social Status of Black Men and Boys.

H.R. 4631, the Protecting Our Students by Terminating Graduate Rates that Add to Debt Act
Issue: Support the reinstatement of Federal Direct Subsidized Loans for graduate students.

Issue: Support the elimination of taxes on non-tuition student scholarship and grant aid.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Education - Dept of, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.

Draft Graduate Medical Education Reform Act
Issue: Support increased funding for the National Health Service Corps, Teaching Health Center GME, and National Disaster Medical Service (NDMS) demonstration pilot. Support increased Medicare support for Graduate Medical Education/physician training.

Issues: Educate Congress and the administration about the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support measures to expand access to mental health care and substance use disorder treatment, including funding for training on substance use disorders, pain management, and safe prescribing practices, enhance enforcement of mental health parity laws, increased financial support for integrated behavioral health models. Support the provision of additional Medicare-supported graduate medical education slots for psychiatry and psychiatry sub-specialties.

P.L. 117-328, Consolidated Appropriations Act, 2023
Support the provision of 200 additional Medicare-supported graduate medical education (GME) positions. Support the extension of COVID-related telehealth flexibilities. Support elimination or delay of Statutory Pay-As-You-Go (PAYGO) Medicare sequester and eliminating or reducing scheduled cuts to the Physician Fee Schedule. Support one-year of continuous Medicaid coverage for children. Support extension of postpartum Medicaid and CHIP coverage for 12 months.

H.R. 1384/ S.445, Mainstreaming Addiction Treatment (MAT) Act of 2021
P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF
Issue: Support suspension of waiver requirement for certain providers to prescribe buprenorphine.

H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021
P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF
Issue: Oppose legislative mandates dictating medical education curriculum on pain management and addiction.

H.R. 7236, Strengthen Kids Mental Health Now Act/ S. 2727 Investing in Kids Mental Health Now Act
Issue: Support increasing Medicaid reimbursement rates for pediatric mental health services through a 100% federal match.

P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.

Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including restrictions on covered entities use of contract pharmacy to distribute covered drugs.

H.R. 4390, Preserving Rules Ordered for the Entities Covered Through 340B Act of 2021 (PROTECT 340B Act)
Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from discriminating against 340B covered entities.

H.R. 3203/S. 773
Issue: Support policy to allow 340B DSH hospitals to remain eligible to participate in the program throughout the current public health emergency even if their DSH adjustment falls below the current threshold due to changes in payer mix as a result of the COVID-19 pandemic.

Issue: Oppose insurance plans that do not meet Affordable Care Act requirements.

Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued.

Issue: Support the ongoing refinement of the two new mandatory alternative payment models, the Radiation Oncology Model and End-stage Renal Disease Treatment Choices Model, to better incentivize high-quality care for all patients.

H.R. 4128/ S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021
S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022
P.L. 117-328, Consolidated Appropriations Act, 2023
Issue: Educate Congress on development of Laboratory Developed Tests at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food and Drug Administration regulation of the development of Laboratory Developed Tests at academic medical centers.

S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022
H.R. 7667, Food and Drug Amendments of 2022 (FDA22)
P.L. 117-328, Consolidated Appropriations Act, 2023
Issue: Support promotion of data sharing and clinical trials results reporting. Support increased clinical trials diversity.

Issue: Development of Enhanced Primary Care Pilot Act proposal

H.R. 2503 / S. 3039, Social Determinants Accelerator Act of 2021
Issue: Support grants to address social determinants of health

H.R. 7585 / S. 4486, Health Equity and Accountability Act
Issue: Support programs to improve health equity and address social determinants of health.

Issue: Support incentives to encourage the inclusion of implicit bias training in medical education and residency training.

Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health.

Issue: Support maternal health initiatives to expand coverage during the postpartum period and expand demonstration project grants.

H.R. 959, Black Maternal Health Momnibus Act of 2021
S. 1695 / H.R. 4387, Maternal Health Quality Improvement Act
S. 1491/ H.R. 769, Rural MOMs Act
H.R. 4387, Maternal Health Quality Improvement Act of 2021
H.R. 925 / S. 347, Data to Save Moms Act
Issue: Support legislative efforts to improve maternal health and reduce rates of maternal mortality, including the Momnibus. Support legislative initiatives to improve data collection to improve maternal health equity.

P.L. 117-159, Bipartisan Safer Communities Act
Issue: Support policies to promote firearm safety, universal background checks, violence prevention programs, extreme risk protection orders, child access safety laws, reinstating assault weapons ban, data infrastructure, hospital based and community violence intervention programs, and programs to address mental and behavioral health impact of gun violence.

Issue: Support funding for Community Violence Interventions / Hospital Based Violence Intervention Programs

P.L. 117-105, Dr. Lorna Breen Health Care Provider Protection Act
Issue: Support grants directed at improving clinician burnout and well-being.

Issue: Provide feedback on implementation of the Provider Relief Fund. Support extension for use of PRF funds.
Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs, including delaying recoupment of MAAP loans.

Issue: Support extension of public health emergency declaration.

Issue: Provide feedback on COVID-19 and pandemic response. Provide feedback on monkeypox response including testing.

S. 3799, PREVENT Pandemics Act
P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF
Issue: Provide feedback on pandemic preparedness legislation, urge inclusion of provisions to support academic medical centers preparedness activities.
Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students and academic medical centers in administering COVID vaccines.

Issue: Support efforts of academic medical centers to respond to public health threats such as monkeypox and COVID-19. Urge establishment and implementation of robust national testing strategy; functional, redundant, and transparent supply chain; improved federal coordination; investments in public health and health care human and other resources; data modernization initiatives; and other actions to improve current and future pandemic response.

H.R. 708, S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout the COVID-19 public health emergency

S. 674 Public Health Infrastructure Saves Lives Act
Issue: Support investments in core public health infrastructure.

Issue: Support ensuring patients are put first, that conscience protections align with medical professionalism standards, and oppose interference in the patient-physician relationship.

Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021.

H.R. 6000, Cures 2.0 Act
Issue: Provide feedback on provisions related to public health, patients and caregivers, FDA, CMS, and research, and ARPA-H.

Issue: Promote strategies to strengthen the health, public health, and research workforces.

H.R. 3671, Doctors of Community Act
Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program.

H.R. 8131, Increasing Competition for Medical Residency Act
Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency.

Issue: Provide guidance on the implementation of the No Surprises Act.

Issue: Provide feedback on proposed modifications to the HIPAA privacy rule.

H.R. 5035 / S. 2982, Child Suicide Prevention and Lethal Means Safety Act
Issue: Support legislation to provide grants to improve suicide prevention and lethal means safety.

Issue: Inform Congress and Administration about medical education on caring for older adults, nutrition, climate change, stigma around addiction, reproductive health, and accelerated medical education training programs.

Issue: Provide feedback on efforts of the academic medicine community to address climate change and decarbonization.

Issue: Support efforts of teaching hospitals to promote patient safety and high-quality care.

H.R. 7152/ S.3534, The Tracking Pathogens Act
P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF
Issue: Support expansion of CDC activities related to genomic sequencing of pathogens.

Issue: Support reignition of Cancer Moonshot.

H.R. 7961, Safety from Violence for Healthcare Employees (SAVE) Act
Issue: Support statutory protections against violence and intimidation for health care workers and provide grants for hospital programs aimed at preventing violence in health care settings.

P.L. 117-263, James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Issue: Support a one year pause in military medical billet reductions in the Military Health System.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), White House Office, Federal Emergency Management Agency (FEMA), Vice President of the U.S., Homeland Security - Dept of (DHS), Natl Security Council (NSC), Defense - Dept of (DOD), Office of Science & Technology Policy (OSTP), Agency for Healthcare Research & Quality (AHRQ)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 6, The American Dream and Promise Act of 2021
S. 264, Dream Act of 2021
Issue: Support policies allowing undocumented students to attend U.S. medical schools and graduate medical education. Support Dreamer eligibility for federal student loans.

H.R. 3541/ S. 1810, Conrad State 30 and Physician Access Reauthorization Act
Issue: Support reauthorization and expansion of the Conrad 30 program, and improvements to physician immigration

Issue: Support policies to ensure timely and predictable processing for immigration of academic medicine community

H.R. 2255/ S. 1024, Healthcare Workforce Resilience Act
Issue: Support reduction of green card backlogs for health professionals

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), White House Office, Executive Office of the President (EOP), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

H.R. 6000, Cures 2.0
Issue: Provide feedback on provisions related to research and ARPA-H. Support inclusion of RISE Act.

H.R. 5585, ARPA-H Act
S.3799, PREVENT Pandemics Act
S. 3819, ARPA-H Act
P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF
Issue: Provide feedback on legislation to establish Advanced Research Project Agency/Authority for Health (ARPA-H).

P.L. 117-328, Consolidated Appropriations Act, 2023, Division FF
Issue: Support clinical trials diversity.

Issue: Support prompt establishment of the Research Policy Board and implementation of the additional reform
efforts required by Section 2034 of the 21st Century Cures Act (P.L. 114-255).

Issue: Support ethical use of fetal tissue in medical research.

Issue: Provide input on criteria for next NIH director.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Office of Science & Technology Policy (OSTP), Executive Office of the President (EOP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issue: Support policies to close the Medicaid coverage gap, including through ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.

Issue: Support programs and funds for safety-net providers. Educate Congress about the impact of Section 203 of the Consolidated Appropriations Act, 2021 and its changes to the Medicaid DSH cap calculation methodology on academic medical centers.

P.L. 117-328, Consolidated Appropriations Act, 2023 Division FF
Issue: Support increased Medicare funding for graduate medical education, including 200 new Medicare-supported GME slots included in the Consolidated Appropriations Act, 2023.

H.R. 2256 / S. 834, Resident Physician Shortage Reduction Act of 2021
H.R. 5376, Build Back Better Act
Issue: Support increased Medicare funding for graduate medical education

S. 1438 Opioid Workforce Act
H.R. 3441 Substance Use Disorder Workforce Act
Issue: Support targeted Medicare funding for graduate medical education for addiction medicine, addiction psychiatry, and pain medicine residency programs

S.1893 / H.R. 8508, Rural Physician Workforce Production Act
Issue: Oppose legislation redesigning Medicare GME payment formulas that reduce current DGME/IME payments to teaching hospitals

Issue: Provide feedback to CMS on its proposed distribution of the 1,000 new GME slots authorized be the Consolidated Appropriations Act, 2021 as described in the 2022 Inpatient Prospective Payment System (IPPS) proposed rule. Support CMS adopting alternative 2 with modifications to allow for more than 1.0 FTE per hospital. Support policy to ensure each qualifying hospital that applies for CAA, 2021 GME positions would receive at least 1 (or a fraction of 1) of the positions before any qualifying hospital receives more than 1 of such positions

Issue: Support Medicare Graduate Medical Education (GME) per resident amount and cap-setting technical corrections and administrative relief.

Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments

Issue: Oppose reduction of Medicare GME/IME payments

Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.

Issue: Oppose establishing nationality-based restrictions on medical residencies supported by Medicare

Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.

Issue: Oppose Medicare hospital, physician, and provider cuts.

H.R. 8850, Fair Access In Residency Act
Issue: Oppose legislative interference in residency training program requirements and policies requiring the Medicare program to consider specific physician licensing exams for residency program applications.

Issue: Oppose overly burdensome Medicaid GME transparency language.

Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.

Issue: Educate Congress on role of academic medicine as it relates to price transparency or disclosure initiatives

H.R.3173 / S.3018, Improving Seniors Timely Access to Care Act
Issue: Protecting patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency

Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs.

Draft Medicare Part D benefit re-design legislation
Issue: Support policies to reduce prescription drug prices

Issue: Support implementation of the 21st Century Cures Act (Cures) interoperability and health data sharing provisions.

Issue: Support changes and improvements to the Medicare Shared Savings Program.

Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

Issue: Educate Congress and policymakers on the financial challenges facing teaching hospitals, medical schools, and faculty practices and the impact on patients access to care and the nations health.

Issue: Support expansion of Medicaid and CHIP coverage during the postpartum period.

S. 610, Protecting Medicare and American Farmers from Sequester Cuts Act
H.R. 315, Medicare Sequester COVID Moratorium Act
S. 748, Medicare Sequester Relief Act
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes.
Issue: Support extension of Medicare sequester moratorium.

P.L. 117-328, Consolidated Appropriations Act, 2023
Issue: Support clearing the PAYGO scorecard to avoid another Medicare sequester due to the use of reconciliation to pass the American Rescue Plan Act.

Issue: Oppose use of extended Medicare sequester and repurposing of unused Provider Relief Fund.

P.L. 117-328, Consolidated Appropriations Act, 2023 Division FF
H.R.8800, Supporting Medicare Providers Act of 2022
Issue: Support a 4.42% increase in the Medicare physician fee schedule that Congress provided in the Consolidated Appropriations Act, 2021 to avoid payment cuts due to budget neutrality requirements.

Issue: Oppose efforts by states to impose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage for certain Medicaid beneficiaries.

Issue: Support making permanent the interim final rule that allows hospitals that unknowingly trigger their Medicare GME caps and per resident amounts to not have that happen and instead retain the ability to build a new resident cap / PRA so long as the cap / PRA is not above a minimum amount.

Issue: Oppose aspects of CMS hospital price transparency rule.

Issue: Oppose site-neutral expansion to excepted off-campus provider-based departments (PBDs).

Issue: Support waiving budget neutrality requirements associated with the E/M code changes or temporarily holding harmless physicians and other health care professionals.

Issue: Oppose finalizing proposed rule for Medicare Coverage of Innovative Technology (MCIT) and definition of reasonable and necessary.

Issue: Oppose enforcement of linking Medicare Conditions of Participation (CoP) compliance with requiring that hospitals report 38 COVID-19 related measures.

Issue: Support continuation of the 3-Day Skilled Nursing Facility (SNF) Stay waiver after the conclusion of the COVID-19 public health emergency.

Issue: Oppose policy of incorporating revenue distinctions into the Medicare Shared Savings Program.

P.L. 117-328, Consolidated Appropriations Act, 2023 Division FF
Issue: Support permanent extension of Medicare telehealth waivers, including removing patient location restrictions and rural site requirements, allowing payment for audio-only services, and reimbursing providers for telehealth services as services delivered in-person. Support 2 year or permanent extension of the waivers.

P.L. 117-328, Consolidated Appropriations Act, 2023 Division FF
H.R. 7053 / S. 3792, Hospital Inpatient Services Modernization Act
Issue: Support extension of Acute Hospital at Home program waiver of 24/7 nursing requirement.
Issue: Support permanent extension of current Covid telehealth flexibilities

HR 1332, the Telehealth Modernization Act
Issue: Support efforts to expand patient access to telehealth

HR 1397, the Telehealth Improvement for Kids Essential Services Act
Issue: Support providing states with guidance to increase telehealth access in Medicaid and CHIP
Issue: Support efforts to improve access to childrens mental health care

H.R. 4040 Advancing Telehealth Beyond COVID-19 Act of 2021
Issue: Support extension of COVID-19 telehealth waivers for two years beyond the end of the COVID-19 public health emergency.

H.R. 7961 - Safety from Violence for Healthcare Employees Act (SAVE Act)Issue: Support funding for hospital-based violence intervention programs and community violence interventions

Issue: Support increased access to behavioral health and substance use disorder treatment services under Medicare and Medicaid. Support expanded Medicare reimbursement for integrated behavioral health Medicare payment codes. Support the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults).

S. 2061 Telemental Health Care Access Act
Issue: Support policy to remove requirement for Medicare beneficiaries to be seen in-person every six months for telehealth visits for mental health services

Issue: Support creation of new Medicare outpatient IME payment in addition to existing Medicare IME payment inpatient methodology. Oppose policies to create IME payments for outpatient services while remaining budget neutral.

Issue: Support efforts to reverse cuts in Medicare OPPS reimbursements to hospitals for drugs acquired under the 340B program.

H.R. 4547, Value in Health Care Act
Issue: Support changes to alternative payment models (APMs) to increase participation in value-based health programs and promote quality care and improved health outcomes.

P.L. 117-328, Consolidated Appropriations Act, 2023
Issue: Support extension of alternative payment model (APM) bonus.

H.R. 3746, Accountable Care in Rural America Act
Issue: Support improving the benchmarking process for the Medicare Shared Savings Program (MSSP) to ensure that all ACOs have an equal opportunity to share in savings regardless of their geographic location.

H.R. 4970, Rural Medical Residency Expansion Act of 2021
Issue: Support providing funds for rural teaching hospitals to expand their residency programs.

Issue: Support efforts to investigate nurse-staffing agencies conduct during the COVID-19 pandemic.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Issue: Support reducing administrative and regulatory burden on scientists and research institutions.

H.R. 4521, America COMPETES Act of 2022
S.1260, United States Innovation and Competition Act of 2021
P.L. 117-167, Supreme Court Funding Act of 2022, Division A (CHIPS Act of 2022)
Issue: Support efforts to promote research integrity, address harassment in science, and address potential for foreign influence in science using a balanced approach, including stakeholder engagement from institutions of higher education. Support exemption of STEM graduates and health professionals from immigration caps.

Issue: Consider strategies to prevent and address harassment in science and medicine

Issue: Urge Congress to let science lead investigations of COVID-19 origins.

Issue: Educate Congress on uses of gain of function research and prevent unreasonable restrictions.

Issue: Support the use of a competitive peer review process for federal research grants and programs.

Issue: Explore opportunities to improve research with cannabinoids.

HR 869 / S 289, Research Investment to Spark the Economy Act
Issue: Support research recovery at federal science agencies due to COVID-19 pandemic.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Office of Science & Technology Policy (OSTP), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB), Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships, including in the VA AIR Commission. Educate Congress on the national physician workforce shortages impact on VA.

H.R. 5721 VA Infrastructure Powers Exceptional Research Act of 2021
P.L. 117-328, Consolidated Appropriations Act, 2023, Division U
Issue: Support Paperwork Reduction Act exemption for VA researchers; support hiring flexibilities for VA research personnel; support dedicated time for research for physician scientists in the VA research program; support dual appointments with academic affiliates.

Issue: Consider opportunities to strengthen the shared missions of research, education, and patient care through existing affiliations.

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Issue: Educate Congress on the community benefit of not-for-profit hospitals and the importance of preserving their tax-exempt status.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes